Idiopathic pulmonary fibrosis trials in Japan
6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in JapanA Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment
- Where
- Fukui, Yoshida-gun, Fukuoka, Fukuoka, Hokkaido, Sapporo, Kanagawa, Yokohama, Kumamoto, Kumamoto, Osaka, Sakai, Shizuoka, Hamamatsu
- Age
- 40 years and over
- People
- 70 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07926321 · EU 2026-527098-13-00 - Phase 3Not yet taking people in JapanLong-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
- Where
- Bunkyo-ku, Bunkyo-Ku, Chiba, Chikushino-shi, Eiheiji-cho, Yoshida-gun, Fukuoka, Ginowan-Shi, Hamamatsu, Himeji-Shi, Hiroshima, Iizuka-shi, Izumo-shi, Kamogawa-Shi, Kobe, Kōriyama, Kumamoto, Kurume-Shi, Matsusaka-shi, Minato-ku, Mitaka-shi, Nagasaki, Nagoya, Naka-gun, Ōta-ku, Sakai, Sapporo, Seto-shi, Shimotsuke, Shinjyu-Ku, Shinjyuku-ku, Takatsuki, Tenri-shi, Tokyo, Ube, Yokohama
- Age
- 18 years and over
- People
- 2,380 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00 - Phase 2Taking peopleA Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Where
- Fukuoka, Hachioji-shi, Hamamatsu, Hiroshima, Kakogawa-shi, Kumagaya-shi, Kumamoto, Matsusaka-shi, Sakaishi, Sendai, Seto-shi, Shimotsuke-shi, Shinjuku-ku, Yokohama
- Age
- 40 years and over
- People
- 359 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07652658 - Phase 2Taking peopleStudy of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
- Where
- Sakai-shi
- Age
- 40 years and over
- People
- 165 worldwide
- Run by
- AbbVie
See details and how to joinNCT07230288 · EU 2024-518013-25-00 - No phaseNot yet taking people in JapanAntifibrotic Therapy Decision-Making in Pulmonary Fibrosis
- Where
- Tokyo
- Age
- 18 years and over
- People
- 40
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07722507 - No phaseTaking peopleSleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease
- Where
- Jōyō
- Age
- 20 years and over
- People
- 120
- Run by
- National Hospital Organization Minami Kyoto Hospital
See details and how to joinNCT05193136